Amanda Nugent, OD
Optometrist · Jensen Beach, FLNPI 1750759775
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,430 of the $5,716 with a category attached, or 77.5%. Johnson & Johnson accounts for 77.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $4,633 and has fallen 88.0% since, to $554 in 2025. Among optometrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $197.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$4K
- Johnson & Johnson Vision Care, Inc.$319
- Tarsus Pharmaceuticals, Inc.$227
- Alcon$184
- Bausch & Lomb Americas Inc.$172
- Glaukos Corporation$136
- plus $249 from 6 others
What the payments were for
- Food & beverage$1,26922%
- Gifts$170%
- Other$4,43077%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $4,430 |
| Johnson & Johnson Vision Care, Inc. | 6 | $319 |
| Tarsus Pharmaceuticals, Inc. | 5 | $227 |
| Alcon | 4 | $184 |
| Bausch & Lomb Americas Inc. | 4 | $172 |
| Glaukos Corporation | 1 | $136 |
| Optovue, Inc. | 1 | $83 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $62 |
| Coopervision Inc. | 3 | $45 |
| Amgen | 1 | $23 |
| Sight Sciences, Inc. | 1 | $17 |
| Carl Zeiss Meditec AG | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$229
- Photrexa Viscous and Photrexa$136
- AcrySof IQ PanOptix UV IOL$125
- INFUSE$122
- XDEMVY$116
How this compares
$5,716 in reported general payments places this provider in the 90th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 34 | $1,374 |
| Latanoprost | 25 | $215 |
| MoxifloxacinMoxifloxacin Hcl | 11 | $156 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Jensen Beach
- Daniel DuranteJensen Beach$110K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
- Jessica SteenDavie$256K
- Mark DunbarMiami$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.